This also imply that patients with coronary artery disease on aspirin are at increased risk of thrombosis compared to chronic heart failure patients on aspirin, and perhaps soluble platelet products such as beta-thromboglobulin may take part in plasma thrombogenesis [34, 35]. Here, PPBP is linked to coronary artery disorder.